Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Sotera Health ( (SHC) ) just unveiled an update.
On January 14, 2025, Sotera Health announced its preliminary revenue results for the full-year 2024, projecting approximately $1.1 billion in revenue, which represents a nearly 5% growth compared to 2023. The company attributes this growth to the resilience of its business model, which effectively serves customers in diverse market conditions. Additionally, Chairman and CEO Michael B. Petras, Jr., provided a business update at the 43rd Annual J.P. Morgan Healthcare Conference, reinforcing the company’s positive financial trajectory and plans for future reporting on February 27, 2025.
More about Sotera Health
Sotera Health Company is a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. Sotera Health operates through three businesses: Sterigenics®, Nordion®, and Nelson Labs®, and is committed to its mission of Safeguarding Global Health®.
YTD Price Performance: -3.89%
Average Trading Volume: 1,214,309
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $3.71B
For an in-depth examination of SHC stock, go to TipRanks’ Stock Analysis page.
